ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 23 Issue : 1
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Expert panel on cost analysis of atrial fibrillation [Anatol J Cardiol]
Anatol J Cardiol. 2013; 13(1): 26-38 | DOI: 10.5152/akd.2013.004  

Expert panel on cost analysis of atrial fibrillation

Ali Serdar Fak1, M. Serdar Küçükoğlu2, Nazire Afşar Fak3, Mesut Demir4, Mustafa Demirtaş5, Sedat Köse6, Murat Özdemir7
1Institute of Cardiology, İstanbul University, İstanbul-Turkey
2İstanbul Üniversitesi Kardiyoloji Enstitüsü, Kardiyoloji Anabilim Dalı, İstanbul, Türkiye
3Department of Neurology, Faculty of Medicine, Marmara University, İstanbul-Turkey
4Department of Cardiology, Faculty of Medicine, Çukurova University Adana-Turkey
5Department of Cardiology Çukurova University Faculty of Medicine, Adana
6Department of Cardiology, Gülhane Military Medical Academy, Ankara, Turkey
7Department of Cardiology, Faculty of Medicine, Gazi University, Ankara-Turkey

 

Objective: To estimate total cost of atrial fibrillation (AF) management concerning acute coronary syndrome, heart failure, stroke and drug related adverse events with respect to clinical practice and available guidelines.

Methods: This cost analysis study was based on identification of total costs related to management of acute coronary syndrome, heart failure, stroke and the drug related adverse events in patients with AF based on standardized questionnaire forms filled by experts according to their daily clinical practice and also to ACCF/AHA/ESC guidelines. Total cost included cost items related to treatment, healthcare resources utilization, and diagnostic test and consultations.

Results: The yearly cost of acute coronary syndrome per patient was 5.478.43 TL according to expert’s view reflecting real clinical practice whereas it was 11.319.44 TL when calculation was based on recommendations in the guidelines. The average total cost of heart failure was 4.523.74 TL according to expert’s view whereas it was 2.925.86 TL based on guidelines. The average total cost of stroke was 5.719.25 TL according to expert’s view but 7.931.18 TL based on guidelines. Among drug related adverse events, only those related to cardiac adverse events were estimated to be higher according to expert view as compared to guideline recommendations (288.65 vs. 150.99 TL).

Conclusions: Reflecting the treatment algorithms in the management of AF and related adverse events, our findings seem to emphasize the extra burden on health economics posed by patients suffering from the uncontrolled disease. 

Keywords: Atrial fibrillation, acute coronary syndrome, heart failure, stroke, adverse events, cost analysis


Ali Serdar Fak, M. Serdar Küçükoğlu, Nazire Afşar Fak, Mesut Demir, Mustafa Demirtaş, Sedat Köse, Murat Özdemir. Expert panel on cost analysis of atrial fibrillation. Anatol J Cardiol. 2013; 13(1): 26-38


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology